19.08.2022 17:16:03

DGAP-DD: Heidelberg Pharma AG english




Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

19.08.2022 / 17:15
The issuer is solely responsible for the content of this announcement.








1. Details of the person discharging managerial responsibilities / person closely associated

a) Name




Title: Dr.
First name: Georg F.
Last name(s): Baur

2. Reason for the notification

a) Position / status




Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Heidelberg Pharma AG

b) LEI
391200E09XYBYITR1W32 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code




Type: Derivative
ISIN: DE000A2888P1

b) Nature of the transaction


Granting of 46,902 subscription rights as part of a capital increase with subscription rights

c) Price(s) and volume(s)




Price(s) Volume(s)
0 EUR 0 EUR

d) Aggregated information




Price Aggregated volume
0 EUR 0 EUR

e) Date of the transaction
18/08/2022; UTC+2

f) Place of the transaction




Outside a trading venue



19.08.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
















Language: English
Company: Heidelberg Pharma AG
Gregor-Mendel-Str. 22
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com



 
End of News DGAP News Service





77387  19.08.2022 



fncls.ssp?fn=show_t_gif&application_id=1418933&application_name=news&site_id=smarthouse

Analysen zu Heidelberg Pharma AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Heidelberg Pharma AG 2,43 4,29% Heidelberg Pharma AG